SCHEMBL13864262

SCHEMBL13864262

CC12CNCC1(c1cc(C(F)(F)F)ccc1F)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.35
HTR2C P28335 4/20 0.35
HTR2B P41595 4/20 0.35
PDE2A O00408 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
TDP2 O95551 1/20 0.33
CHRNB2 P17787 2/20 0.33
CHRNA4 P43681 2/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
AR P10275 1/20 0.32
IDO1 P14902 1/20 0.32
BACE1 P56817 3/20 0.32
BACE2 Q9Y5Z0 1/20 0.32
SLC6A4 P31645 2/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10235172 0.81 PDE2A (0.37) HTR2AHTR2CHTR2BPDE2AHDAC3
SCHEMBL2895515 0.76 OPRM1 (0.42) HTR2CPDE2ACHRNB2CHRNA4CHRNB4
SCHEMBL3468969 0.76 OPRM1 (0.42) HTR2CPDE2ACHRNB2CHRNA4CHRNB4
SCHEMBL3468930 0.76 OPRM1 (0.42) HTR2CPDE2ACHRNB2CHRNA4CHRNB4
SCHEMBL13823320 0.73 HTR2C (0.39) HTR2AHTR2CHTR2BBACE1SLC6A4
SCHEMBL9231710 0.73 HDAC3 (0.41) PDE2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL13823155 0.72 PGR (0.32)
SCHEMBL10107293 0.69 TDP2 (0.40) PDE2AHDAC3HDAC1HDAC2HDAC6
SCHEMBL2271110 0.67 HDAC3 (0.40) HTR2AHTR2CHTR2BPDE2AHDAC3
SCHEMBL11914466 0.67 KCNH2 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2060570-A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors Glaxo Group Limited (GB) 2009-05-20 EP disclosed